Premium
Modulation of mucosal permeability by vasoactive intestinal peptide or lidocaine affects the adjustment of luminal hypotonicity in rat duodenum
Author(s) -
Nylander O.,
Sjöblom M.
Publication year - 2007
Publication title -
acta physiologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.591
H-Index - 116
eISSN - 1748-1716
pISSN - 1748-1708
DOI - 10.1111/j.1748-1716.2006.01649.x
Subject(s) - paracellular transport , vasoactive intestinal peptide , endocrinology , medicine , permeability (electromagnetism) , intestinal permeability , duodenum , chemistry , neuropeptide , biochemistry , receptor , membrane
Aims: To examine whether modulation of paracellular solute permeability affects the capability of the duodenum to adjust luminal osmolality. Methods: Proximal duodenum was perfused with a hypotonic NaCl solution and effects on paracellular permeability to 51 Cr‐EDTA, motility, anion secretion, net fluid flux and perfusate osmolality determined in anaesthetized rats in the absence and presence of the COX‐2 inhibitor parecoxib. Vasoactive intestinal peptide (VIP) was used to reduce and lidocaine to augment the hypotonicity‐induced increase in paracellular permeability. Results: Luminal hypotonicity slightly increased paracellular permeability in control animals. Parecoxib induced motility, increased electrolyte and fluid secretion, potentiated the hypotonicity‐induced rise in paracellular permeability and enhanced the capability to adjust luminal osmolality. VIP, given to control animals stimulated electrolyte and fluid secretion and augmented the capability to adjust luminal osmolality. Administration of VIP to parecoxib‐treated animals increased secretion further, markedly reduced the hypotonicity‐induced increase in permeability but did not change the osmolality‐adjusting capability. Luminal lidocaine potentiated the hypotonicity‐induced increase in permeability, reduced the hypotonicity‐induced net fluid absorption and the osmolality‐adjusting capability was 50% greater than in controls. Lidocaine, given to parecoxib‐treated animals potentiated the hypotonicity‐induced increase in permeability, reduced the hypotonicity‐induced net fluid absorption but did not change the osmolality‐adjusting capability. Conclusions: Vasoactive intestinal peptide reduces the osmolality‐adjusting capacity of the duodenum by inhibiting paracellular solute permeability but improves this capacity by stimulating active electrolyte and fluid secretion. In contrast, lidocaine improves the osmolality‐adjusting capability by augmenting paracellular solute transport but depresses it by reducing the hypotonicity‐induced net fluid absorption.